Bristol Myers Squibb Director Peter J. Arduini Acquires Deferred Share Units
BRISTOL MYERS SQUIBB CO
Subscribe to track BMY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing: Bristol Myers Squibb Co ($BMY) Insider: Peter J. Arduini (Director) Type: Acquisition (Award/Deferred Compensation) Security: Deferred Share Units Shares: 560.897 @ $62.40 (~$35,000.00) Total Holdings: 74,077.176 units Significance: Low (Routine Director Deferred Compensation)
Comprehensive Analysis
Executive Summary
On October 2, 2026, Bristol Myers Squibb Co ($BMY) filed a Form 4 disclosing that Director Peter J. Arduini acquired 560.897 Deferred Share Units on September 30, 2026, valued at $62.40 per share, representing an aggregate transaction value of approximately $35,000.
Transaction Details
- Security: Deferred Share Units (convertible into common stock upon separation from service or a pre-determined date)
- Transaction Code: A (Grant, award, or other acquisition)
- Volume: 560.897 units
- Price per Unit: $62.40
- Post-Transaction Holdings: 74,077.176 units (held directly)
Strategic & Contextual Analysis
The transaction reflects quarterly director compensation under Bristol-Myers Squibb Company's 1987 Deferred Compensation Plan for Non-Employee Directors rather than an open-market purchase. Consequently, this filing reflects standard non-employee director compensation arrangements and holds low signaling value for market participants.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.